A Safety Evaluation of ECG Intervals and Blood Pressure in Normal Healthy Volunteers After Use of Nebivolol, Atenolol, Moxifloxacin, or Placebo
Clinical trial NCT00158093 · COMPLETED
Trial details
- NCT number
- NCT00158093
- Sponsor
- Mylan Bertek Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.